Zevra Therapeutics (NASDAQ:ZVRA – Get Rating) is one of 986 public companies in the “Pharmaceutical preparations” industry, but how does it compare to its competitors? We will compare Zevra Therapeutics to related businesses based on the strength of its profitability, analyst recommendations, institutional ownership, earnings, valuation, dividends and risk. Volatility & Risk Zevra Therapeutics has […]
StockNews.com began coverage on shares of Zevra Therapeutics (NASDAQ:KMPH – Get Rating) in a research report released on Saturday. The firm issued a hold rating on the specialty pharmaceutical company’s stock. Zevra Therapeutics Stock Down 0.3 % Zevra Therapeutics stock opened at $5.81 on Friday. The stock has a 50-day moving average of $5.41 and […]
StockNews.com initiated coverage on shares of Zevra Therapeutics (NASDAQ:KMPH – Get Rating) in a report issued on Saturday. The firm set a “hold” rating on the specialty pharmaceutical company’s stock. Zevra Therapeutics Price Performance Shares of KMPH stock opened at $5.81 on Friday. Zevra Therapeutics has a 12-month low of $4.00 and a 12-month high […]